Stereotactic Body Radiotherapy For Castration-Sensitive Prostate Cancer Bone Oligometastases

被引：0
|
作者：
Fanetti, G. [1 ]
Marvaso, G. [1 ]
Rese, A. [2 ]
Ricotti, R. [1 ]
Ciardo, D. [1 ]
Rondi, E. [3 ]
Comi, S. [3 ]
Cattani, F. [3 ]
Zerini, D. [1 ]
Fodor, C. [1 ]
De Cobelli, O. [4 ]
Orecchia, R. [5 ]
Jereczek-Fossa, B. [1 ]
机构：
[1] European Inst Oncol, Div Radiat Oncol, Milan, Italy
[2] Federico II Univ Hosp, Div Radiat Oncol, Naples, Italy
[3] European Inst Oncol, Unit Med Phys, Milan, Italy
[4] European Inst Oncol, Div Urol, Milan, Italy
[5] European Inst Oncol, Dept Med Imaging & Radiat Sci, Milan, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)31874-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1565
引用
收藏
页码：S843 / S844
页数：2
相关论文
共 50 条
  • [21] Apalutamide for the treatment of metastatic castration-sensitive prostate cancer
    Dror, Corinne Maurice
    Chi, Kim Nguyen
    FUTURE ONCOLOGY, 2020, 16 (35) : 2905 - 2916
  • [22] Re: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 202 (04): : 661 - 661
  • [23] Index lesion dosimetry for 177Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Grkovski, Milan
    O'Donoghue, Joseph
    Imber, Brandon
    Andl, George
    Tu, Cheng
    Lafontaine, Daniel
    Schwartz, Jazmin
    Thor, Maria
    Zelefsky, Michael
    Humm, John
    Bodei, Lisa
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [24] The prognostic value of pain in castration-sensitive prostate cancer
    Iacovelli, Roberto
    Ciccarese, Chiara
    Caffo, Orazio
    De Giorgi, Ugo
    Tucci, Marcello
    Mosillo, Claudia
    Bimbatti, Davide
    Pierantoni, Francesco
    Maines, Francesca
    Casadei, Chiara
    Buttigliero, Consuelo
    Milella, Michele
    Tortora, Giampaolo
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 654 - 660
  • [25] Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer
    Hoy, Sheridan M.
    DRUGS, 2020, 80 (15) : 1579 - 1585
  • [26] Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT TROD 09-004 Study
    Onal, Cem
    Ozyigit, Gokhan
    Akgun, Zuleyha
    Atalar, Banu
    Igdem, Sefik
    Oymak, Ezgi
    Agaoglu, Fulya
    Selek, Ugur
    Guler, Ozan Cem
    Hurmuz, Pervin
    Mustafayev, Teuto Zoto
    Akyol, Fadil
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (06) : 465 - 470
  • [27] Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
    Priyanka H. Patel
    Cheng Lee Chaw
    Alison C. Tree
    Mansour Sharabiani
    Nicholas J. van As
    World Journal of Urology, 2019, 37 : 2615 - 2621
  • [28] Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
    Patel, Priyanka H.
    Chaw, Cheng Lee
    Tree, Alison C.
    Sharabiani, Mansour
    van As, Nicholas J.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (12) : 2615 - 2621
  • [29] STEREOTACTIC BODY RADIOTHERAPY FOR PULMONARY OLIGOMETASTASES
    Lagerwaard, F. J.
    LUNG CANCER, 2011, 71 : S17 - S17
  • [30] Stereotactic Body Radiotherapy in bone oligometastatic prostate cancer patients
    Trippa, F.
    Arcidiacono, F.
    Di Marzo, A.
    Draghini, L.
    Anselmo, P.
    Terenzi, S.
    Casale, M.
    Fabiani, S.
    Maranzano, E.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S850 - S851
12345